학술논문
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.
Document Type
Academic Journal
Author
Beaney T; Imperial Clinical Trials Unit, Imperial College London, London, UK.; Department of Primary Care and Public Health, Imperial College London, London, UK.; Burrell LM; Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia.; Castillo RR; Adventist University of the Philippines College of Medicine, Silang, Cavite, Philippines.; Charchar FJ; Federation University Australia, Ballarat, VIC, Australia.; Cro S; Imperial Clinical Trials Unit, Imperial College London, London, UK.; Damasceno A; Department of Physiology, Eduardo Mondlane University, Maputo, Mozambique.; Kruger R; Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.; Hypertension in Africa Research Team; South African Medical Research Council, North-West University, Potchefstroom, South Africa.; Nilsson PM; Department of History of Medicine, Lund University, Skane University Hospital, Malmo, Sweden.; Prabhakaran D; Department of Research and Policy, Public Health Foundation of India, Haryana, India.; Ramirez AJ; Department of Pharmacology and Physiology, Hospital Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina.; Schlaich MP; Dobney Hypertension Centre, Royal Perth Hospital Campus, University of Western Australia, Perth, WA, Australia.; Schutte AE; Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.; Hypertension in Africa Research Team; South African Medical Research Council, North-West University, Potchefstroom, South Africa.; Tomaszewski M; Faculty of Biology, Medicine and Health, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.; Touyz R; Institute of Cardiovascular and Medical Sciences, Cardiovascular Research Centre, Glasgow, Scotland.; Wang JG; Department of Hypertension, Rujin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Weber MA; State University of New York, Downstate Medical Centre, New York, USA.; Poulter NR; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Source
Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE
Subject
Language
English
Abstract
Aims: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries.
Methods and Results: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension.
Conclusion: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
(© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.)
Methods and Results: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension.
Conclusion: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
(© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.)